ALFA News
Straight from the exchange filing
Every announcement Alkem Laboratories has filed with the exchanges that we have reported, newest first. Each story links the original filing.
Every Alkem Laboratories announcement on ALFA FilingsSee filings →Reference market data from a third-party provider, as of the most recent story. Not a valuation or a recommendation.
Alkem Laboratories launches NeuCeno (cenobamate) for partial-onset seizures in India, targeting 9.4 million patients with a once-daily anti-seizure medication.
Alkem Laboratories launches Renocia Exo, India's first patented Ginsenoside Exosome-based hair serum, targeting the dermatology market. Market cap ₹62,048 Cr.
Alkem Laboratories launches India's first semaglutide single-shot pre-filled syringes starting at ₹350, expanding treatment for diabetes and obesity management.
